Found: 13
Select item for more details and to access through your institution.
Efficacy and safety of humanized anti‐CD19‐CAR‐T therapy following intensive lymphodepleting chemotherapy for refractory/relapsed B acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 2, p. 212, doi. 10.1111/bjh.16623
- By:
- Publication type:
- Article
A Prospective Trial Comparing Haploidentical Donor Transplantation With Cord Blood Versus HLA-Matched Sibling Donor Transplantation for Hematologic Malignancy Patients.
- Published in:
- Cell Transplantation, 2022, v. 31, p. 1, doi. 10.1177/09636897221076050
- By:
- Publication type:
- Article
Corrigendum: ROS-mediated iron overload injures the hematopoiesis of bone marrow by damaging hematopoietic stem/progenitor cells in mice.
- Published in:
- Scientific Reports, 2017, p. 41900, doi. 10.1038/srep41900
- By:
- Publication type:
- Article
Overexpression of Both ERG11 and ABC2 Genes Might Be Responsible for Itraconazole Resistance in Clinical Isolates of Candida krusei.
- Published in:
- PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0136185
- By:
- Publication type:
- Article
Effects of Iron Overload on the Bone Marrow Microenvironment in Mice.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0120219
- By:
- Publication type:
- Article
CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual disease.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3501, doi. 10.1007/s00262-021-02941-4
- By:
- Publication type:
- Article
Successful treatment of second-time CAR-T 19 therapy after failure of first-time CAR-T 19 and ibrutinib therapy in relapsed mantle cell lymphoma.
- Published in:
- Advances in Clinical & Experimental Medicine, 2022, v. 31, n. 3, p. 327, doi. 10.17219/acem/145948
- By:
- Publication type:
- Article
Low-dose administration of prednisone has a good effect on the treatment of prolonged hematologic toxicity post-CD19 CAR-T cell therapy.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1139559
- By:
- Publication type:
- Article
Free iron catalyzes oxidative damage to hematopoietic cells/mesenchymal stem cells in vitro and suppresses hematopoiesis in iron overload patients.
- Published in:
- European Journal of Haematology, 2013, v. 91, n. 3, p. 249, doi. 10.1111/ejh.12159
- By:
- Publication type:
- Article
Metagenomic Next-Generation Sequencing for Diagnostically Challenging Mucormycosis in Patients with Hematological Malignancies.
- Published in:
- Infection & Drug Resistance, 2022, v. 15, p. 7509, doi. 10.2147/IDR.S393201
- By:
- Publication type:
- Article
The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure.
- Published in:
- Infection & Drug Resistance, 2022, v. 15, p. 3549, doi. 10.2147/idr.s393201
- By:
- Publication type:
- Article
ROS-mediated iron overload injures the hematopoiesis of bone marrow by damaging hematopoietic stem/progenitor cells in mice.
- Published in:
- Scientific Reports, 2015, p. 10181, doi. 10.1038/srep10181
- By:
- Publication type:
- Article
Chronic neutrophilic leukemia with overexpression of EVI-1, and concurrent CSF3R and SETBP1 mutations: A case report.
- Published in:
- Oncology Letters, 2015, v. 10, n. 3, p. 1694, doi. 10.3892/ol.2015.3485
- By:
- Publication type:
- Article